May 27, 2021
Existing biosimilars are safe, effective alternatives to their reference biologics, and are increasingly being incorporated into oncology treatment guidelines.
Technological advances that have emerged in the years since biologic agents entered the market allow for the careful assessment of “critical clinical...
May 20, 2021
Systemic treatment for advanced urothelial cancer is quickly evolving. On this week’s podcast, Arjun Balar, MD, director of the genitourinary medical oncology program at New York University discusses his approach amid changing times with guest host Alan Lyss, MD, a community-based medical oncologist and clinical...
May 13, 2021
A “very basic” type of gene therapy could potentially cure hemophilia, but a major hurdle has been the lack of an effective mode of delivery. Recent strides in using adeno-associated virus (AAV) vectors are changing that, and Glenn Pierce, MD, World Federation of Hemophilia Vice President, Medical,...
May 6, 2021
At least 17 cases of thrombosis and thrombocytopenia have been
reported in patients who received the Johnson & Johnson COVID-19
vaccine in the United States.
Such events have been reported in patients who received the
AstraZeneca vaccine as well.
In this episode, Adam C.
Cuker, MD, of the University of Pennsylvania,...
Apr 29, 2021
The combined clinical cell-cycle risk (CCR) score uses clinical and genetic factors to assess the risk of metastasis after radiation therapy in patients with prostate cancer.
The CCR score has proven accurate in studies and can guide post-radiation treatment decisions in practice, according to Jonathan D. Tward, MD,...